Therapeutic choices for patients with hemophilia and high-titer inhibitors-Reference-Cited by-同舟云学术

Therapeutic choices for patients with hemophilia and high-titer inhibitors

Published:2001 Issue:4 Volume:67 Page:240-246
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Kulkarni Roshni,Aledort Louis M.,Berntorp Erik,Brackman Hans H.,Brown Deborah,Cohen Alan R.,Ewing Nadia P.,Gringeri Alessandro,Gruppo Ralph,Hoots Keith,Leissenger Cindy,Peerlinck Katheliijne,Poon Man-Chiu,Wong Wing-Yen

Publisher

Wiley

Subject

Hematology

Reference25 articles.

1. Incidence of inhibitors in haemophilia A patients - a review of recent studies of recombinant and plasma-derived factor VIII concentrates

2. Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs

3. German recommendations for immune tolerance therapy in type A haemophiliacs with antibodies

4. Treatment options for bleeding episodes in patients undergoing immune tolerance therapy

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy, safety and cost of emicizumab prophylaxis in haemophilia A patients with inhibitors: A nationwide observational study in Taiwan;Haemophilia;2023-10-11

2. PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors;Haemophilia;2021-10-06

3. Bridging the Missing Link with Emicizumab: A Bispecific Antibody for Treatment of Hemophilia A;Thrombosis and Haemostasis;2020-07-27

4. Current Considerations on Characterization of Immune Response to Multi-Domain Biotherapeutics;BioDrugs;2019-10-22

5. Measurement of plasma and platelet tissue factor pathway inhibitor, factor V and Protein S in people with haemophilia;Haemophilia;2019-10-14